Similar articles

• SSRI prescriptions and the rate of suicide.

  Olfson M, Shaffer D. Olfson M, et al. Am J Psychiatry. 2007 Dec;164(12):1907-8; author reply 1908-10. doi: 10.1176/appi.ajp.2007.07091467. Am J Psychiatry. 2007. PMID: 18056247 No abstract available.
• Withdrawal of attention rather than pharmacological treatment affects suicide rates in depressed children and adolescents.

  Wohlfarth T, Boer F, van den Brink W. Wohlfarth T, et al. Am J Psychiatry. 2007 Dec;164(12):1908; author reply 1908-10. doi: 10.1176/appi.ajp.2007.07091448. Am J Psychiatry. 2007. PMID: 18056249 No abstract available.
• Pediatric prescribing practices and the FDA Black-box warning on antidepressants.

  Cheung A, Sacks D, Dewa CS, Pong J, Levitt A. Cheung A, et al. J Dev Behav Pediatr. 2008 Jun;29(3):213-5. doi: 10.1097/DBP.0b013e31817bd7c9. J Dev Behav Pediatr. 2008. PMID: 18550990
• [The psychopharmacological treatment of depressive disorders in childhood and adolescence - developments and standards since the «black box» warning].

  Plener PL, Fegert JM, Kölch MG. Plener PL, et al. Z Kinder Jugendpsychiatr Psychother. 2012 Nov;40(6):365-71. doi: 10.1024/1422-4917/a000196. Z Kinder Jugendpsychiatr Psychother. 2012. PMID: 23109125 Review. German.
• ACNP Task Force report on SSRIs and suicidal behavior in youth.

  Mann JJ, Emslie G, Baldessarini RJ, Beardslee W, Fawcett JA, Goodwin FK, Leon AC, Meltzer HY, Ryan ND, Shaffer D, Wagner KD. Mann JJ, et al. Neuropsychopharmacology. 2006 Mar;31(3):473-92. doi: 10.1038/sj.npp.1300958. Neuropsychopharmacology. 2006. PMID: 16319919 Review.